HIV Patients in the HCUP Database: A Study of Hospital Utilization and Costs

Abstract

This study examines the utilization of hospital care by HIV patients in all hospitals in eight states (California, Colorado, Florida, Kansas, New Jersey, New York, Pennsylvania, and South Carolina), and examines the cost of hospital care for HIV patients in six of these states (California, Colorado, Kansas, New Jersey, New York, and South Carolina). The eight states in the sample account for more than 52% of all persons living with AIDS in the United States; the six states account for 39%. The unit of observation in both studies is a hospital admission by a patient with HIV. Hospital data were obtained from the Healthcare Cost and Utilization Project (HCUP), State Inpatient Database (SID), which is maintained by the Agency for Healthcare Research and Quality (AHRQ). The HCUP contains hospital discharge data and is a federal/state/industry partnership to build a multistate health care data system. Using multivariate analytic techniques and data from 2000, results indicate that cost and length of a hospital stay vary significantly across states after accounting for a patient's gender, insurance type, race, age, and number of diagnoses, as well as the teaching status and ownership category of the hospital.

References

Alagiri

Summers

Kates

, 2002. Spending on the HIV/AIDS Epidemic: Trends in U.S. Spending on HIV/AIDS. Menlo Park, Calif.: The Henry J. Kaiser Family Foundation.

Aldridge

Dannielle

Doyle

, 2002. National ADAP Monitoring Project: Interim Technical Report. Supported by a grant from The Henry J. Kaiser Family Foundation, Menlo Park, Calif.

Anderson

K. H.

Mitchell

J. M.

, 1997. Expenditures on Services for Persons with Acquired Immunodeficiency Syndrome Under a Medicaid Home and Community-Based Waiver Program. Medical Care 35: 425–439.

Bozzette

Ake

C. F.

Tam

H. K.

Chang

S. C.

Louis

T. A.

, 2003. Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection. New England Journal of Medicine 348: 702–710.

Bozzette

S. A.

Berry

S. H.

Duan

Franke

M. R.

Leibowitz

A. A.

Lefkowitz

Emmons

Senterfitt

J. W.

Berk

M. L.

Morton

S. C.

Shapiro

M. F.

, 1998. The Care of HIV-Infected Adults in the United States. New England Journal of Medicine 339: 1897–1928.

Bozzette

S. A.

Joyce

McCaffrey

D. F.

Leibowitz

A. A.

Morton

S. C.

Berry

S. H.

Rastegar

Timberlake

Shapiro

M. F.

Goldman

D. P.

, 2001. Expenditures for the Care of HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy. New England Journal of Medicine 344: 817–823.

Buchanan

R. J.

Chakravorty

B. J.

, 1997. Medicaid Home and Community-Based Waiver Programs: Providing Services to People with AIDS. Health Care Financing Review 18: 83–103.

Conviser

Gamliel

Honberg

, 1998. Health-Based Payment for HIV/AIDS in Medicaid Managed Care Programs Health Care Financing Review 19: 63–82.

Cowart

M. E.

Mitchell

J. M.

, 1995. Florida's Medicaid AIDS Waiver: An Assessment of Dimensions of Quality. Health Care Financing Review 16: 141–153.

10.

Fasciano

N. J.

Cherlow

L. A.

Turner

B. J.

Thornton

C. V.

, 1998. Profile of Medicare Beneficiaries with AIDS: Application of AIDS Casefinding Algorithm. Health Care Financing Review 19: 19–38.

11.

Friedman

De La Mare

Andrews

Roxanne

Hamilton

, 2002. Practical Options for Estimating Cost of Hospital Inpatient Stays. Journal of Health Care Financing 29: 1–13.

12.

Gebo

K. A.

Chaisson

R. E.

Folkemer

J. G.

Barltett

J. G.

Moore

R. D.

, 1999. Costs of HIV Medical Care in the Era of Highly Active Antiretroviral Therapy. AIDS 13: 963–969.

13.

Goldman

D. P.

Leibowitz

A. A.

Shapiro

M. F.

Bozzette

S. A.

, 2001. The Impact of State Policy on the Costs of HIV Infection. Medical Care Research and Review 58: 31–53.

14.

Hardy

A. M.

Rauch

Echenberg

Morgan

W. M.

Curran

J. W.

, 1986. The Economic Impact of the First 10,000 Cases of Acquired Immunodeficiency Syndrome in the United States. Journal of the American Medical Association 255: 209–211.

15.

Hellinger

F. J.

1998. The Cost and Financing of Care for Persons with HIV Disease: An Overview. Health Care Financing Review 19: 5–18.

16.

Hellinger

F. J.

1993. The Lifetime Cost of Treating a Person with HIV. Journal of the American Medical Association, 270: 474–478.

17.

Hirschel

2003. Beware of Drug Holidays Before Salvage Therapy. New England Journal of Medicine 349: 27–28.

18.

HIV Capitation Risk Adjustment Conference Report . 1997. Conference supported by the Health Resources and Services Administration, U.S. Department of Health and Human Services in conjunction with The Henry J. Kaiser Family Foundation, Washington, D.C.

19.

Keiser

Kvanli

M. B.

Dianna

B. T.

Reisch

Nassar

J. W.

Naiel

C. G.

Skiest

, 1999. Protease Inhibitor-Based Therapy is Associated with Decreased HIV-Related Health Care Costs in Men Treated at a Veterans Administration Hospital. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20: 28–33.

20.

Krentz

H. B.

Auld

M. C.

Gill

M. J.

, 2003. The Changing Direct Costs of Medical Care for Patients with HIV/AIDS: 1995–2001. Canadian Medical Association Journal 169: 106–110.

21.

Lane

H. C.

Neaton

J. D.

, 2003. When to Start Therapy for HIV infection: A Swinging Pendulum in Search of Data. Annals of Internal Medicine 138: 680–681.

22.

Ledergerber

Egger

Opravil

Telenti

Hirechel

Battegay

Vernazza

Sudre

Flepp

Furrer

Francioli

Weber

, 1999. Clinical Progression and Virological Failure on Highly Active Antiretroviral Therapy in HIV-1 Patients: A Prospective Cohort Study. Swiss HIV Cohort Study. Lancet 53: 863–868.

23.

Mellors

Montaner

, 2000. Salvage Therapy for HIV-1 Infection –- The Challenge Grows. Lancet 355: 1435.

24.

Merzel

Crystal

Sambamoorthi

Karus

Kurland

, 1992. New Jersey's Medicaid Waiver for Acquired Immunodeficiency Syndrome. Health Care Financing Review 13: 27–44.

25.

Miller

N. A.

Richmond

Harrington

, 1999. Trends and Issues in the Medicaid 1915c Waiver Program. Health Care Financing Review 20: 139–159.

26.

Mocroft

Ledergerber

Katlama

Kirk

Reiss

Monforte

M. A. D'Arminio

Knysz

Dietrich

Phillips

A. N.

Lundgren

J. D.

, 2003. Decline in the AIDS and Death Rates in the EuroSIDA Study: An Observational Study. Lancet 362: 22–29.

27.

Mole

Ockrim

Holodniy

, 1999. Decreased Medical Expenditures for Care of HIV-Seropositive Patients: The Impact of Highly Active Antiretroviral Therapy at a U.S. Veterans Affairs Medical Center. Pharmacoeconomics 16: 307–315.

28.

Moore

R. D.

Bartlett

J. G.

, 1996. Combination Antiretroviral Therapy in HIV Infection: An Economic Perspective. Pharmacoeconomics 10: 109–113.

29.

Moore

R. D.

Chaisson

R. E.

, 1997. Costs to Medicaid of Advancing Immunosuppression in an Urban HIV-Infected Patient Population in Maryland. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14 (3): 223–231.

30.

Moore

R. D.

Stanton

Gopalan

Chaisson

R. E.

, 1994. Racial Differences in Drug Therapy for HIV Disease in an Urban Community. New England Journal of Medicine. 330: 763–768.

31.

Palella

F. J.

Delaney

K. M.

Moorman

A. C.

Loveless

M. O.

Fuhrer

J. F.

Satten

G. A.

, D. J. Aschman, and S. D. Holmerg and the HIV Outpatient Study Investigators. 1998. Declining Morbidity and Mortality Among Patients with Advanced Human Immunodeficiency Virus Infection. New England Journal of Medicine 338: 853–908.

32.

Palella

F. J.

Deloria-Knoll

Chmiel

J. S.

Moorman

A. C.

Wood

K. C.

Greenberg

A. E.

Holmberg

S. D.

, 2003. Survival Benefit of Initiating Antiretroviral Therapy in HIV-infected Persons at Different CD4 Cell Strata. Annals of Internal Medicine 138: 620–626.

33.

Rosenblum

Buehler

J. W.

Morgan

M. W.

Costa

Hidalgo

Holmes

Lieb

Shields

Whyte

, 1993. HIV Infection in Hospitalized Patients and Medicaid Enrollees: The Accuracy of Medical Record Coding. American Journal of Public Health 83: 1457–1459.

34.

SAS/STAT User's Guide, Version 8, Volume 2. 1999. Cary, N.C.: SAS Institute Inc.

35.

Scitovsky

A. A.

Rice

D. P.

, 1987. Estimates of the Direct and Indirect Economic Costs of Acquired Immune Deficiency Syndrome. Public Health Reports 102: 1–17.

36.

Sendi

Gafni

, 2003. The HAART Side of Allocation. Canadian Medical Association Journal 169: 120–121.

37.

Shapiro

M. F.

Morton

S. C.

McCaffrey

D. F.

Senterfitt

J. W.

Fleishman

J. A.

Perlman

J. F.

Athey

L. A.

Keesey

J. W.

Goldman

D. P.

Berry

S. H.

Bozzette

S. A.

, 1999. Variations in the Care of HIV-Infected Adults in the United States: Results from the HIV Cost and Services Utilization Study. Journal of the American Medical Association 281 (4): 2305–2315.

38.

State of New York. 1997. AIDS in New York State through 1996. Albany: New York State Department of Health.

39.

Torres

R. A.

Barr

, 1997. Impact of Combination Therapy for HIV Infection on Inpatient Census. New England Journal of Medicine 336: 1531–1532.

40.

Trachtenberg

J. D.

Sande

M. A.

, 2002. Emerging Resistance to Nonnucleoside Reverse Transcriptase Inhibitors: A Warning and a Challenge. Journal of the American Medical Association 288 (2): 239–241.

41.

U.S. Centers for Disease Control and Prevention (CDC). 2001. HIV/AIDS Surveillance Report: U.S. HIV and AIDS Cases Reported through June 2001. 13 (1).

42.

Weissman

J. S.

Clearly

P. D.

Seage

G. R.

Gatsonis

Haas

J. S.

Chasan-Taber

Epstein

A. M.

, 1996. The Influence of Health-Related Quality of Life and Social Characteristics on Hospital Use by Patients with AIDS in the Boston Health Study. Medical Care 34 (10): 1037–1056.

43.

Yeni

P. G.

Hammer

S. M.

Carpenter

C. J.

Cooper

D. A.

Fischl

M. A.

Gatell

J. M.

Gazzard

B. G.

Hirsch

M. S.

Jacobsen

D. M.

Katzenstein

D. A.

Montaner

J. S. G.

Richman

D. D.

Saag

M. S.

Schecter

Schooley

R. T.

Thompson

M. A.

Vella

Volberding

P. A.

, 2002. Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel. Journal of the American Medical Association 286 (2): 222–235.